On May 10, the Hadassah Medical Organization delegation that traveled to Argentina to share its medical expertise in overcoming COVID-19 met with top medical professionals from the Center for Medical Education and Clinical Research (CEMIC), which is the Argentina equivalent of the National Academy of Medicine.
During this meeting, Director General Prof. Hugo Magonza and Prof. Pablo Rozik, head of the Department of Psychiatry, briefed the Hadassah delegation on the health situation in Argentina.
At that time, Argentinian statistics indicated:
• a total of 3,165,121 confirmed cases of COVID-19
• 260,242 active cases
• 2,837,058 recovered
• 67,821 deaths
The Hadassah medical experts then met with 40 top directors of hospitals and COVID-19 departments at Garrahan Hospital, the country’s leading free public pediatric hospital. At Garrahan, Prof. Yoram Weiss, director of Hadassah Hospital Ein Kerem, Prof. Sigal Sviri, head of Hadassah’s COVID-19 intensive care units; and nurse Claudia Poggi, a specialist in complex COVID-19 care, gave presentations about their experiences in battling COVID-19. Their presentations were followed by a question and answer session where the medical professionals had the opportunity to exchange ideas.
Hadassah has collaborative agreements with both Garrahan and CEMIC to share medical expertise.
Later, the Hadassah team met with Raúl Olmos, a Hadassah donor and the owner of the Olmos Group, a leading Argentine holding company in the provision of health services, and BASA Salud, a health network of hospitals in the province of Buenos Aires. Olmos was joined by his team of medical professionals.
In addition, the Hadassah delegation visited with ANMAT, the National Administration of Drugs, Foods and Medical Devices, Argentina’s version of the US Food and Drug Administration, to discuss the ways that some of the COVID-19 drugs that were developed at Hadassah could be produced in Argentina.